The Accelerating Cancer Cures Advisory Committee is comprised of senior oncology leaders in the collaborating companies. A valuable resource for Damon Runyon scientists, committee members are available for discussions and advice about the process of translating discoveries into therapeutics.

Chair

Richard B. Gaynor, MD
President and Chief of Research and Development
BioNTech US

I-Fen Chang, PharmD
VP, Global Medical Oncology TA Head
Amgen, Inc.

Charles S. Fuchs, MD, MPH
Senior Vice President - Global Head of Hematology and Oncology Product Development
Genentech, Inc. & Roche

Jennifer Lauchle, MD
Global Head of Translational Clinical Oncology
Novartis

Theodora Ross, MD, PhD
Head, Oncology Research and Development
AbbVie

Eric H. Rubin, MD
Senior Vice President and Therapeutic Area Head
Oncology Early Development
Merck and Co., Inc.

H. Michael Shepard, PhD
Biooncology, LLC 
Professor, Shanghai Jiao Tong University, Shanghai, China and Adjunct Professor, Department of. Biological Sciences, Indiana University, Bloomington, IN

  • You can support our innovative researchers.